Nano-SOD1

N/A

Report date: 2025/01/26 19:10:34

Base Information

Drug NameNano-SOD1
Drug Alias Namesuperoxide dismutase (National University of Science and Technology MISIS/Lomonosov Moscow State University/Helmholtz National Medical Research Center/University of North Carolina)
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionSuperoxide dismutase stimulantsFree radicals scavengers
TargetsFree radicalsSuperoxide dismutase
Therapy Area/IndicationsOcular inflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRussian Federation
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational University Of Science & Technology "Misis"
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina, GreensboroMoscow Scientific-Research Institute of Eye DiseasesNational University Of Science & Technology "Misis" +[4] 
Inactive CompaniesN/A
Active IndicationsOcular inflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A